ATE401860T1 - Volumensparende arzneiform zur kontrollierten freisetzung - Google Patents

Volumensparende arzneiform zur kontrollierten freisetzung

Info

Publication number
ATE401860T1
ATE401860T1 AT03721484T AT03721484T ATE401860T1 AT E401860 T1 ATE401860 T1 AT E401860T1 AT 03721484 T AT03721484 T AT 03721484T AT 03721484 T AT03721484 T AT 03721484T AT E401860 T1 ATE401860 T1 AT E401860T1
Authority
AT
Austria
Prior art keywords
active agent
layer
controlled release
membrane system
dosage form
Prior art date
Application number
AT03721484T
Other languages
English (en)
Inventor
Patrick Wong
Francisco Jao
David Edgren
Robert Skluzacek
Shu Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE401860T1 publication Critical patent/ATE401860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03721484T 2002-03-29 2003-03-28 Volumensparende arzneiform zur kontrollierten freisetzung ATE401860T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36871402P 2002-03-29 2002-03-29
US40406102P 2002-08-16 2002-08-16

Publications (1)

Publication Number Publication Date
ATE401860T1 true ATE401860T1 (de) 2008-08-15

Family

ID=28678251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03721484T ATE401860T1 (de) 2002-03-29 2003-03-28 Volumensparende arzneiform zur kontrollierten freisetzung

Country Status (8)

Country Link
US (2) US20030185888A1 (de)
EP (1) EP1499289B1 (de)
JP (1) JP2005521706A (de)
AT (1) ATE401860T1 (de)
AU (1) AU2003224794A1 (de)
CA (1) CA2481236A1 (de)
DE (1) DE60322371D1 (de)
WO (1) WO2003082207A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
WO2005020959A2 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
JP2007511519A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 液状投薬形態物におけるトピラメートの制御放出
CN1997372B (zh) * 2004-06-24 2010-06-02 西梯茜生命工学股份有限公司 包含依他康那唑的固态分散剂的制造方法及其医药组成物
CA2571554A1 (en) * 2004-06-28 2006-01-19 Alza Corporation A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
CA2616181C (en) * 2005-07-28 2015-02-17 Shire Llc Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
US20070098796A1 (en) 2005-10-31 2007-05-03 Rekhi Gurvinder S Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
US20070098791A1 (en) * 2005-10-31 2007-05-03 Rekhi Gurvinder S Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
WO2008074153A1 (en) 2006-12-18 2008-06-26 Electronic Dietary Foods Inc. Device for delivery of a substance
CA2923102C (en) * 2007-08-13 2019-10-15 Omeho Life Sciences Inc. Abuse resistant drugs, method of use and method of making
US20090148532A1 (en) * 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms
WO2010104494A1 (en) * 2009-03-09 2010-09-16 Theraquest Biosciences, Inc. Modified release pharmaceutical compositions of buprenorphine
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8377453B2 (en) 2008-03-11 2013-02-19 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
WO2010015840A1 (en) * 2008-08-08 2010-02-11 Cipla Limited Osmotic delivery device with modified release
CN101856339A (zh) * 2009-04-09 2010-10-13 广州柏赛罗药业有限公司 一种控释制剂及其制备方法
AU2010325960C1 (en) 2009-12-02 2015-08-06 Adamas Pharma, Llc Amantadine compositions and methods of use
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US20130220349A1 (en) * 2012-02-23 2013-08-29 Celanese Acetate Llc Deformable tablet with water triggered catalyst release
US20140105976A1 (en) * 2012-10-11 2014-04-17 Theravida, Inc. Pharmaceutical formulations of pilocarpine
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
WO2017127073A1 (en) 2016-01-20 2017-07-27 Theravida, Inc. Methods and compositions for treating hyperhidrosis
US11964048B2 (en) * 2020-12-18 2024-04-23 Amneal Complex Products Research Llc Sustained release compositions comprising liothyronine
CN116262109A (zh) * 2021-12-13 2023-06-16 燃点(南京)生物医药科技有限公司 一种硝苯地平控释片新的半透膜包衣方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4058122A (en) * 1976-02-02 1977-11-15 Alza Corporation Osmotic system with laminated wall formed of different materials
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5869078A (en) * 1996-04-25 1999-02-09 Medtronic Inc. Implantable variable permeability drug infusion techniques
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
EP1652516A3 (de) * 1998-11-02 2006-05-17 ALZA Corporation Osmotisch kontrollierte Freigabe von Wirkstoffen

Also Published As

Publication number Publication date
CA2481236A1 (en) 2003-10-09
DE60322371D1 (de) 2008-09-04
EP1499289B1 (de) 2008-07-23
WO2003082207A2 (en) 2003-10-09
WO2003082207A3 (en) 2004-05-13
JP2005521706A (ja) 2005-07-21
EP1499289A2 (de) 2005-01-26
AU2003224794A8 (en) 2003-10-13
AU2003224794A1 (en) 2003-10-13
US20030185888A1 (en) 2003-10-02
US20070184112A1 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
DE60322371D1 (de) Volumensparende arzneiform zur kontrollierten freisetzung
AR048185A1 (es) Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico
PA8513701A1 (es) Inhibidor de la glucogeno fosforilasa poco soluble
AR046290A1 (es) Agente terapeutico para el mesotelioma
ECSP088422A (es) Composiciones farmacéuticas sólidas que contienen pregabalina
ATE381926T2 (de) Vitaminzusammenstellung mit verzögerter freigabe
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
RU2004134728A (ru) Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
BRPI0409652A (pt) tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete
ATE374601T1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein- wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
ATE262890T1 (de) Schnell dispergierende darreichungsformen, die fischgelatine enthalten
ES2557988T3 (es) Método para tratar enfermedades de próstata basado en el suministro local de principios activos
DE602005001765D1 (de) Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
WO2005097064A3 (en) Taste-masked drugs in rupturing multiparticulates
AR061047A1 (es) Comprimido bicapa para la prevencion de los accidentes cardiovasculares, su uso, y metodo para la prevencion de accidentes cardiovasculares
AR034517A1 (es) Formulacion farmaceutica
SE0200895D0 (sv) New pharmaceutical composition
AR053541A1 (es) Combinacion de xolair con agente inmunosupresor
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina
WO2006030402A3 (en) Dual compartment osmotic delivery device
CL2004000983A1 (es) Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2007035515A3 (en) A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration
WO2005123134A3 (en) A controlled release delivery system for metformin
DE602007012845D1 (de) Neue dipeptidylpeptidase-iv-inhibitoren und verfahren zur ihrer herstellung und pharmazeutische zusammensetzung, die diese enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties